Restructuring the Business Portfolio and Optimizing the Allocation of Management Resources

「We will also review the surgical business included in “Surgical Endoscopy” and “Other Treatment Areas” within the surgical intervention business from these perspectives and consider various strategic options to optimize performance and create further value.」

「Under the put option agreement mentioned above, the company completed the transfer of the Orthopedic business on 12 July 2024.」

「We concluded that transferring オリンパステルモバイオマテリアル株式会社 and the FHO Group to Polaris Capital Group would be the optimal approach for increasing the group’s corporate value and achieving autonomous and sustainable growth in the Orthopedic business, enabling us to focus on these fields.」

「Under the agreement, the company completed the transfer of the business on 3 July 2023.」

「The company completed the transfer on 3 April 2023.」

「The company entered into an agreement on 29 August 2022 to transfer all shares of Evident and plans to transfer all shares in January 2023.」

「With 1 April 2022 as the effective date, the company conducted a company split under which its Scientific business was transferred to 株式会社エビデント, a newly established wholly owned subsidiary.」

「As a result, we decided to establish management structures suited to the characteristics of each business in the Medical and Scientific businesses, centered on the two businesses mentioned above. We concluded that this would accelerate efforts toward sustainable growth and improved profitability in each business and contribute to increasing the corporate value of the group as a whole, and therefore decided to incorporate the Scientific business as a separate company.」

「The company entered into an agreement dated 28 May 2021 to transfer all shares of its consolidated subsidiary オリンパスシステムズ株式会社 to Accenture株式会社 and completed the transfer procedures on 31 August 2021.」

「The company entered into an agreement dated 28 May 2021 to transfer all shares of its consolidated subsidiary オリンパスシステムズ株式会社 to Accenture株式会社. The transfer of the shares under the agreement was scheduled to be completed by the end of August 2021.」

「Under this agreement, the company completed the transfer of the shares on 1 January 2021.」

「On 30 September 2020, the company entered into a definitive agreement with OJ Holdings Co., Ltd., a special-purpose company established by Japan Industrial Partners, Inc. (JIP), under which the company’s Imaging business would be transferred through an absorption-type company split to a newly established wholly owned subsidiary, referred to below as the “new Imaging company,” and 95% of the shares in the new Imaging company would be transferred to OJ Holdings.」

「On 24 June 2020, the company entered into a letter of intent with Japan Industrial Partners, Inc. regarding the transfer of its Imaging business. Following due diligence and further discussions, the company aims to enter into a definitive legally binding agreement for the transaction by 30 September 2020.」

「Business Portfolio Focus and Selectivity」

「In the Medical business, in accordance with Transform Medical, announced together with Transform Olympus, we will reorganize the Medical business, optimize and rationalize its operating structure, and strengthen our competitiveness in the global medtech industry.」

「The operating loss in Other businesses narrowed as the company streamlined non-core business domains to concentrate management resources on its business domains, and as a result of the transfer of a subsidiary’s business in the same period of the previous fiscal year, among other factors.」

「Treatment of urinary tract stones in the urology business is a priority strategic area under our 16CSP. Through this business acquisition, we will develop and manufacture lithotripsy systems in-house and enhance our competitiveness in the urology business.」

「Under 16CSP, the group continued to advance initiatives for sustainable development during the fiscal year, including strategic investment in growth areas and the pursuit of business efficiency through operational reforms.」

「Revenue from Other businesses declined as the company proceeded to streamline non-core business domains, including the transfer of its subsidiary NOC日本アウトソーシング株式会社 on 31 October 2016.」

「Revenue from Other businesses declined as the company proceeded to streamline non-core business domains, including the transfer of its subsidiary NOC日本アウトソーシング株式会社 on 31 October 2016.」

「Through this acquisition, we will acquire ISM’s IP video distribution technology developed in medical settings and its business platform for systems integration. This will strengthen the operating-room systems integration identified as a priority under 16CSP, enable us to provide a better healthcare environment, and contribute to society by helping realize health, security and peace of mind, and spiritual well-being for people around the world.」

「株式会社アダチ, formerly an equity-method affiliate of the company, was excluded from the scope of equity-method accounting from the first quarter of the current consolidated accounting period following the company’s sale of all its shares.」

「The company entered into an agreement on 30 September 2016 to transfer the shares of its consolidated subsidiary NOCアウトソーシング株式会社 to the Longreach Group and completed the transfer on 31 October of the same year.」

「Through these initiatives, we will establish a foundation and build an aggressive business portfolio to achieve sustainable development beyond the milestone of the company’s 100th anniversary in 2019, and work to increase corporate value.」

「The group continued to vigorously advance the core strategies of its medium-term vision, a medium-term management plan beginning in the fiscal year ending March 2013: restructuring the business portfolio and optimizing the allocation of management resources, reviewing the cost structure, strengthening its financial position, and rebuilding governance.」